Incepta scales up production of drug used to treat mild Covid-19
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Wednesday
February 08, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
WEDNESDAY, FEBRUARY 08, 2023
Incepta scales up production of drug used to treat mild Covid-19

Pharma

TBS Report
06 April, 2020, 08:30 pm
Last modified: 06 April, 2020, 10:10 pm

Related News

  • Semiconductor, pharma should get more attention
  • Pharma industry needs to prepare for headwinds
  • US move to negotiate drug prices a rare defeat for Big Pharma
  • Pharma exports may soar to $5b by 2027: Salman F Rahman
  • Incepta to market nasal Covid vaccine

Incepta scales up production of drug used to treat mild Covid-19

The local drug maker increased production after getting instruction from the Directorate General of Drug Administration

TBS Report
06 April, 2020, 08:30 pm
Last modified: 06 April, 2020, 10:10 pm
Incepta scales up production of drug used to treat mild Covid-19

Incepta Pharmaceuticals has boosted its production of Reconil – a medication in the hydroxychloroquine category – that is being used to treat mild Covid-19 patients in some countries.

The local drug maker in a statement on Monday said they have increased production as per instructions of the Directorate General of Drug Administration.

"The directorate has asked us to manufacture this medicine and keep it in stock," Incepta said.

Although there are two pharmaceutical companies in Bangladesh that make this medicine, Incepta claims that its product has been widely used in the country for over 15 years.

The company said the Disease Control Division of the Ministry of Health and Family Welfare has published a national guideline for clinical management as preparation and a plan of response to control the outbreak of Covid-19.

The guideline mentioned the use of hydroxychloroquine to treat Covid-19 patients in specific situations.

It said various global drug regulatory agencies are advocating this medicine as a treatment for this deadly disease.

The United States Food and Drug Administration has given emergency authorisation for using this drug in coronavirus treatment. China and France are also using the drug to treat Covid-19 patients.

The Indian Medical Association has not only approved this medicine to be used as treatment, but also as a preventive treatment for Covid-19. They have authorised the prophylactic use of hydroxychloroquine for asymptomatic healthcare professionals as well as asymptomatic individuals who have come in contact with laboratory-confirmed coronavirus patients, Incepta claims.

Keeping in mind the country's future course of action against the coronavirus, Incepta has delivered 30 lakh tablets to the Central Medical Store Depot of the government and donated 3 lakh tablets to the drug administration directorate.

Reconil has been approved by the United Kingdom Medicines and Healthcare products Regulatory Agency. Incepta has been successfully exporting Reconil to the UK for many years. 

In addition to this, Incepta will soon launch Favipiravir and a Ritonavir-Lopinavir combination drug, and is also trying to launch Remidesivir and other drugs that are being considered as potential treatment options for Covid-19 by many global experts.

Incepta / Pharma / Reconil

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • RMG turns to India from China to get cheaper man-made yarn
    RMG turns to India from China to get cheaper man-made yarn
  • Country's revenue earnings were Tk40,000cr more in last fiscal: Finance Minister
    Country's revenue earnings were Tk40,000cr more in last fiscal: Finance Minister
  • The world's richest person is trying to head off a succession battle
    The world's richest person is trying to head off a succession battle

MOST VIEWED

  • Photo: Courtesy
    Four directors to buy 9 lakh Square Pharma shares
  • Sanofi Bangladesh renamed Synovia Pharma
    Sanofi Bangladesh renamed Synovia Pharma
  • Pharma on a Tk1 trillion journey
    Pharma on a Tk1 trillion journey
  • Beximco Pharmaceuticals Acquires Sanofi Bangladesh
    Beximco Pharma inks Sanofi acquisition deal
  • TBS Today: Pharmaceutical industry eyes on localisation of raw materials
    TBS Today: Pharmaceutical industry eyes on localisation of raw materials
  • Two Covid-19 drugs boost Beacon Pharma’s turnover, profits
    Two Covid-19 drugs boost Beacon Pharma’s turnover, profits

Related News

  • Semiconductor, pharma should get more attention
  • Pharma industry needs to prepare for headwinds
  • US move to negotiate drug prices a rare defeat for Big Pharma
  • Pharma exports may soar to $5b by 2027: Salman F Rahman
  • Incepta to market nasal Covid vaccine

Features

Photo: Reuters

A tragedy that will also shake up the region's geopolitics

9h | Panorama
Nimah designed by Compass Architects- Wooden tiles. Photo: Junaid Hasan Pranto

Trendy flooring designs to upgrade any space

20h | Habitat
Benefits of having high ceilings in your new home

Benefits of having high ceilings in your new home

19h | Habitat
Each Reverse Osmosi plant can produce approximately 8,000 litres of drinking water a day for around 250 families. Photo: Sadiqur Rahman

A drop in the ocean of persistent water crisis

21h | Panorama

More Videos from TBS

30% companies see double-digit growth even in hard times

30% companies see double-digit growth even in hard times

12h | TBS Insight
Challenging time waiting for RMG

Challenging time waiting for RMG

19h | TBS Round Table
"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

19h | TBS Graduates
10 cricketers who have played over 400 T20 matches

10 cricketers who have played over 400 T20 matches

19h | TBS SPORTS

Most Read

1
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Master plan for futuristic Chattogram city in the making
Districts

Master plan for futuristic Chattogram city in the making

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Crime

Prime Distribution MD Mamun arrested in fraud case

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]